Phage susceptibility testing and infectious titer determination through wide-field lensless monitoring of phage plaque growth.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2021
2021
Historique:
received:
05
10
2020
accepted:
08
03
2021
entrez:
23
3
2021
pubmed:
24
3
2021
medline:
14
10
2021
Statut:
epublish
Résumé
The growing number of drug-resistant bacterial infections worldwide is driving renewed interest in phage therapy. Based on the use of a personalized cocktail composed of highly specific bacterial viruses, this therapy relies on a range of tests on agar media to determine the most active phage on a given bacterial target (phage susceptibility testing), or to isolate new lytic phages from an environmental sample (enrichment of phage banks). However, these culture-based techniques are still solely interpreted through direct visual detection of plaques. The main objective of this work is to investigate computer-assisted methods in order to ease and accelerate diagnosis in phage therapy but also to study phage plaque growth kinetics. For this purpose, we designed a custom wide-field lensless imaging device, which allows continuous monitoring over a very large area sensor (3.3 cm2). Here we report bacterial susceptibility to Staphylococcus aureus phage in 3 hr and estimation of infectious titer in 8 hr 20 min. These are much shorter time-to-results than the 12 to 24 hours traditionally needed, since naked eye observation and counting of phage plaques is still the most widely used technique for susceptibility testing prior to phage therapy. Moreover, the continuous monitoring of the samples enables the study of plaque growth kinetics, which enables a deeper understanding of the interaction between phage and bacteria. Finally, thanks to the 4.3 μm resolution, we detect phage-resistant bacterial microcolonies of Klebsiella pneumoniae inside the boundaries of phage plaques and thus show that our prototype is also a suitable device to track phage resistance. Lensless imaging is therefore an all-in-one method that could easily be implemented in cost-effective and compact devices in phage laboratories to help with phage therapy diagnosis.
Identifiants
pubmed: 33755710
doi: 10.1371/journal.pone.0248917
pii: PONE-D-20-31260
pmc: PMC7987195
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0248917Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
J Infect Dis. 2017 Mar 1;215(5):703-712
pubmed: 28007922
J Anim Sci. 2013 Aug;91(8):3930-9
pubmed: 23893999
J Glob Antimicrob Resist. 2019 Dec;19:255-261
pubmed: 31100499
J Bacteriol. 2016 May 27;198(12):1783-93
pubmed: 27068593
PLoS One. 2007 Aug 29;2(8):e799
pubmed: 17726529
J Clin Invest. 1961 Nov;40:2064-75
pubmed: 14488221
J Appl Bacteriol. 1982 Aug;53(1):1-17
pubmed: 6757237
J Appl Bacteriol. 1977 Jun;42(3):417-21
pubmed: 407206
Biophys J. 1992 Jun;61(6):1540-9
pubmed: 1617137
Lab Chip. 2008 Jan;8(1):98-106
pubmed: 18094767
Phys Rev E Stat Nonlin Soft Matter Phys. 2004 Mar;69(3 Pt 1):031909
pubmed: 15089324
Biotechnol Bioeng. 1996 Nov 5;52(3):438-42
pubmed: 18629915
Viruses. 2018 Jun 30;10(7):
pubmed: 29966329
Lett Appl Microbiol. 2010 Feb;50(2):192-7
pubmed: 20002571
Microbiome. 2015 Nov 17;3:64
pubmed: 26577924
Viruses. 2018 Apr 10;10(4):
pubmed: 29642590
Front Microbiol. 2015 Nov 13;6:1271
pubmed: 26617601
Nature. 1948 May 15;161(4098):777
pubmed: 18860291
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Front Microbiol. 2018 Aug 07;9:1832
pubmed: 30131795
Lett Appl Microbiol. 2005;41(6):482-6
pubmed: 16305674
PLoS One. 2017 Apr 3;12(4):e0174723
pubmed: 28369067
Gene. 1981 Apr;13(3):221-5
pubmed: 6790348
Bacteriophage. 2011 Mar;1(2):66-85
pubmed: 22334863
Clin Otolaryngol. 2009 Aug;34(4):349-57
pubmed: 19673983
Analyst. 2014 Aug 7;139(15):3727-34
pubmed: 24611157
Ann Burns Fire Disasters. 2015 Mar 31;28(1):13-20
pubmed: 26668557
J Theor Biol. 1964 May;6(3):413-31
pubmed: 5875213
Front Med (Lausanne). 2020 Nov 16;7:570572
pubmed: 33304911
Viruses. 2018 Feb 06;10(2):
pubmed: 29415431
Appl Environ Microbiol. 2008 Aug;74(16):5113-20
pubmed: 18586961
Lancet Infect Dis. 2019 Jan;19(1):35-45
pubmed: 30292481
Antimicrob Agents Chemother. 2012 Jul;56(7):3568-75
pubmed: 22491690
Appl Environ Microbiol. 1980 Jan;39(1):85-91
pubmed: 7356323
Nat Biotechnol. 1996 Apr;14(4):491-3
pubmed: 9630926